M&A Accounts for a Third of China's Outbound Investment in 1st Half--Xinhua
China's nonfinancial direct outbound investment rose 48% to $35.4 billion in the first half of this year from a year ago, with mergers and acquisitions activities accounting for one-third of the investment, the official Xinhua News Agency reported Sunday, citing the Ministry of Commerce head Chen
AT&T Announces New Pacts With Two Unions
AT&T (T) reached tentative agreements with the Communications Workers of America in wireline-contract negotiations for the midwest region and AT&T Corp., a CWA Communications and Technologies unit, the company announced Saturday.
As Big U.S. Bond Dealers Retreat as Middlemen, Smaller Firms Step Up
As bulge-bracket dealers scale back their roles as middlemen in bond trading to conform to new regulations and corporate strategies, a host of smaller broker-dealers have been scurrying to fill the void.
India May Soon Discuss Boeing Compensation for Delayed Jet Delivery - Report
India's federal cabinet is expected to discuss the compensation jet maker Boeing Co. (BA) has to pay state-run carrier Air India for the delay in its delivery of Dreamliners, the Press Trust of India reported the civil aviation minister as saying Saturday.
U.S. ITC Rules Kodak Patent Invalid in Case Against RIM
The U.S. International Trade Commission has upheld an earlier decision ruling against Eastman Kodak Co. (EKDKQ) in its patent-infringement case against BlackBerry maker Research in Motion Ltd. (RIMM, RIM.T).
Eldest Son of Li Ka-shing Starts to Take Control of Family Businesses
Victor Li, the eldest son of Asia's richest man, Li Ka-shing, has started to take control of his family business empire after an asset transfer earlier this week, a move to consolidate his father's succession plan.
Fresenius Kabi Acquires U.S. Blood-Transfusion Company Fenwal
German health-care company Fresenius SE & Co. KGaA (FRE.XE, FSNUY) late Friday said its Fresenius Kabi unit will acquire Fenwal Holdings Inc., a blood-transfusion-technology company, as part of the company's strategy to expand in the medical-devices/transfusion-technology segment.